StockGlow

Swedish Orphan Biovitrum AB (publ) (B6E.F)

Swedish Orphan Biovitrum AB (publ), a biopharma company, provides medicines in the areas of haematology, immunology, and specialty care in Europe, North America, the Middle East, Asia, and Australia.

42.70+0.00%Healthcare
Compare B6E.F with
StockGlow Score
95
Bullish
BearishBullish
1 year ago+80.8%

The outlook

Swedish Orphan Biovitrum AB (publ) currently reads as bullish based on above its 50- & 200-day averages, 95% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.

What’s behind the score

Price trendAbove its 50- & 200-day averages
52-week range95% of the way from its 52-week low to high
Market cap
$14.89B
52-wk high
43.62
52-wk low
23.62
50-day avg
41.18
200-day avg
35.80
Trailing P/E
118.6

Similar stocks

RDDA.FDr. Reddy's Laboratories Limited$10.10+0.00%CJH.FCanSino Biologics Inc.$2.52+0.00%GU5.FGuangzhou Baiyunshan Pharmaceutical Holdings Company Limited$1.72-0.58%B4X.FBangkok Expressway and Metro Public Company Limited$0.16+0.00%LDZA.FAspen Pharmacare Holdings Limited$7.60+0.66%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy